Total Revenues in 2Q25 Were $106.7 Million
2Q25 Net Income Was $0.6 Million and Adjusted EBITDA Was $15.4 Million
ROSARIO, Argentina–(BUSINESS WIRE)– Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a leader in agricultural productivity solutions, announced financial results for the fiscal second quarter ended December 31, 2024. All financial results are expressed in U.S. dollars and in accordance with International Financial Reporting Standards.
Financial & Business Highlights
Revenues in 2Q25 totaled $106.7 million, a 24% decline from the record-high $140.2 million in 2Q24. The decrease was driven by economic constraints in Argentina, which significantly contracted the market for crop protection and specialty fertilizers.
Operating profit was $7.9 million and net income was $0.6 million. Adjusted EBITDA for the quarter stood at $15.4 million, primarily driven by performance in Argentina.
New strategy defined for the seed business: Bioceres is exiting breeding and seed production activities to focus on trait development and strategic partnerships.
- Partnership with GDM to develop next-generation soybean varieties.
- Trigall Genetics to focus on HB4 wheat trait development, with breeding programs transferred to Florimond Desprez.
- Bioceres now fully controls HB4 technology rights outside of Latin America.
Leadership Changes: Milen Marinov appointed as Chief Commercial Officer.
Management Review
CEO Federico Trucco commented: “2024 has shown that growth in agriculture is rarely linear. Argentina’s challenging market has impacted our first-half performance. Despite maintaining or gaining market share across key segments, we are implementing two significant strategic changes to unlock our portfolio’s full commercial potential.
Firstly, we have appointed Milen Marinov as our new Chief Commercial Officer to streamline commercial operations and expand partnerships.
Secondly, we are sharpening our focus on patented seed traits, exiting breeding and seed production, and partnering with industry leaders. Our agreement with GDM will advance new soybean solutions, while our wheat joint venture with Florimond Desprez will now focus solely on HB4 wheat development.”
CFO Enrique Lopez Lecube noted: “While the Argentine market has been challenging, we view this setback as temporary. Our market share has remained stable despite reduced farmer spending. Moving forward, we will focus on capital allocation, cost efficiency, and an asset-light business model to enhance profitability.”
Key Financial Metrics
| Metric | 2Q24 | 2Q25 | % Change |
|---|---|---|---|
| Total Revenue | $140.2M | $106.7M | -24% |
| Gross Profit | $51.5M | $45.1M | -12% |
| Gross Margin | 37% | 42% | +557 bps |
| GAAP Net Income | $1.2M | $0.6M | -51% |
| Adjusted EBITDA | $24.1M | $15.4M | -36% |
2Q25 Summary:
Total revenues for 2Q25 fell by 24%, primarily due to tight farm economics in Argentina. Farmer purchasing behavior shifted due to reduced margins and high inventories from previous aggressive purchasing. Sales in Crop Protection and Crop Nutrition declined but maintained market share, while sales in Seed and Integrated Products were affected by strategic shifts in the business.
Looking Ahead:
Bioceres remains optimistic about long-term growth. By focusing on innovative technologies, capital efficiency, and global expansion, the company is positioning itself to benefit from the eventual recovery of the Argentine market.
Source – Biocerescrops
Leave a Reply